发明名称 Phosphorylation modifications of apoptin
摘要 The invention describes phosphorylated Apoptin. Apoptin is tumor-specifically phosphorylated and thereby part of the Apoptin apoptotic pathway in tumor cells is elucidated. The invention opens the way for new therapeutic possibilities, for example novel therapeutic compounds that can work alone or, sequentially to, or jointly with other known compounds. The invention further describes the use of tumor-specifically phosphorylation of Apoptin for diagnostie purposes. Such a diagnostic purpose can, for example, be a method for detecting the presence of cancer cells or cells that are cancer prone or a method to identify a putative cancer inducing agent or a method for the in vitro treatment effect of Apoptin on tumor cells by testing the phosphorylation state of Apoptin. Even more, the invention provides possibilities to further elucidate the apoptotic pathway and to identify for example crucial mediators of phosphorylation in human tumor cells. Interfering with such a mediator could provide new anti-cancer therapies.
申请公布号 EP1199363(A1) 申请公布日期 2002.04.24
申请号 EP20000203652 申请日期 2000.10.20
申请人 LEADD B.V. 发明人 NOTEBORN, MATHIEU HUBERTUS MARIA;ROHN, JENNIFER LEIGH
分类号 A61K38/00;A61K38/16;A61K38/17;A61K48/00;C07K14/01;C07K14/47;C07K16/08;C07K16/18;C12N15/34;G01N33/68 主分类号 A61K38/00
代理机构 代理人
主权项
地址